Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.81B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$834M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$709M |
| 4 |
SPDR Gold Trust
GLD
|
+$686M |
| 5 |
Coca-Cola
KO
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.57B |
| 2 |
Qualcomm
QCOM
|
+$698M |
| 3 |
Blackstone
BX
|
+$691M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$563M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$540M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.6% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Communication Services | 7.68% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Opko Health
OPK
$1.04B
| $3.22M | ﹤0.01% |
1,542,898
-159,361
| -9% | -$326K |
|
3277
Fate Therapeutics
FATE
$294M
| $3.22M | ﹤0.01% |
207,466
-62,957
| -23% | -$1.21M |
|
3278
CorVel
CRVL
$3.25B
| $3.22M | ﹤0.01% |
127,596
-89,655
| -41% | -$2.55M |
|
|
RWW
3279
DELISTED
Invesco S&P Financials Revenue ETF
RWW
| $3.22M | ﹤0.01% |
47,209
-2,533
| -5% | -$170K |
|
3280
Quad
QUAD
$506M
| $3.21M | ﹤0.01% |
305,866
+295,867
| +2,959% | +$2.77M |
|
|
PMO
3281
Franklin Municipal Opportunities Trust
PMO
$290M
| $3.21M | ﹤0.01% |
245,858
+7,510
| +3% | +$98.6K |
|
|
NEWR
3282
DELISTED
New Relic, Inc.
NEWR
| $3.21M | ﹤0.01% |
52,268
-254,397
| -83% | -$18.4M |
|
|
TECD
3283
DELISTED
Tech Data Corp
TECD
| $3.21M | ﹤0.01% |
30,813
+5,912
| +24% | +$576K |
|
3284
Nabors Industries
NBR
$1.35B
| $3.2M | ﹤0.01% |
34,236
-6,577
| -16% | -$740K |
|
3285
Globus Medical
GMED
$11.5B
| $3.19M | ﹤0.01% |
62,446
-23,974
| -28% | -$1.14M |
|
3286
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
| $3.19M | ﹤0.01% |
223,462
+41,091
| +23% | +$584K |
|
3287
Marcus & Millichap
MMI
$1.2B
| $3.19M | ﹤0.01% |
89,837
-18,767
| -17% | -$640K |
|
3288
Forrester Research
FORR
$224M
| $3.19M | ﹤0.01% |
99,140
+49,348
| +99% | +$1.95M |
|
3289
Blue Owl Capital
OBDC
$5.87B
| $3.18M | ﹤0.01% |
+201,664
| New | +$3.23M |
|
3290
Cohen & Steers
CNS
$4.4B
| $3.18M | ﹤0.01% |
57,818
-4,398
| -7% | -$233K |
|
3291
Central Pacific Financial
CPF
$1B
| $3.18M | ﹤0.01% |
111,839
-115,930
| -51% | -$3.34M |
|
3292
TFS Financial
TFSL
$4.93B
| $3.17M | ﹤0.01% |
176,154
-2,091
| -1% | -$37.5K |
|
3293
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.3B
| $3.17M | ﹤0.01% |
57,720
+965
| +2% | +$52.6K |
|
3294
Chesapeake Utilities
CPK
$3.26B
| $3.16M | ﹤0.01% |
33,192
+4,032
| +14% | +$377K |
|
|
FNI
3295
DELISTED
First Trust Chindia ETF
FNI
| $3.16M | ﹤0.01% |
92,003
-21,417
| -19% | -$749K |
|
|
MRTX
3296
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.16M | ﹤0.01% |
40,528
+23,218
| +134% | +$2.18M |
|
3297
Fastly Inc
FSLY
$4.78B
| $3.15M | ﹤0.01% |
131,331
+49,531
| +61% | +$1.17M |
|
3298
First Citizens BancShares
FCNCA
$25.6B
| $3.15M | ﹤0.01% |
6,677
+1,793
| +37% | +$816K |
|
|
CIR
3299
DELISTED
CIRCOR International, Inc
CIR
| $3.15M | ﹤0.01% |
83,751
-118,766
| -59% | -$4.52M |
|
3300
Cytokinetics
CYTK
$10.2B
| $3.14M | ﹤0.01% |
276,108
-10,128
| -4% | -$127K |
|
Similar funds
Morgan Stanley's Q3 2019 Portfolio in Review
As of Q3 2019, Morgan Stanley held 6,992 positions worth $378B, up 0.54% from $376B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.7%. Morgan Stanley opened 161 new positions and exited 167, leaving the 6,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2019 buy was Gaotu Techedu: 6,761,203 shares worth $104M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.81B increase.
- Morgan Stanley's biggest Q3 2019 reduction was Invesco QQQ Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited Worldpay, Inc. in Q3 2019, selling an estimated $563M.
- Morgan Stanley's ten largest holdings make up 16% of its $378B portfolio in Q3 2019.
- Morgan Stanley opened 161 new positions and closed 167 in Q3 2019.
- Morgan Stanley's portfolio value rose 0.54% quarter-over-quarter to $378B.
Based on Morgan Stanley's 13F filing for Q3 2019, filed 14 Nov 2019.